We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

TBN:NYSETamboran Resources Corporation Analysis

Data as of 2026-09-02 - not real-time

$39.83

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Tamboran Resources Corporation is bullish at $39.83, with short-term averages leading the long-term ones. The last 30 days have gained 19.8%. Momentum indicators put RSI at 70.4 (overbought) with MACD reading bullish. The recent range runs from support at $32.05 up to resistance at $41.94.
The company is not currently profitable on a trailing basis, so earnings multiples offer no valuation support. Sell-side targets cluster 38.5% above the current quote.
On a 1-10 scale the risk profile lands at 6 — elevated. With 30-day volatility of 39.8%, a beta of -0.08 and a maximum drawdown of 38.1%, position sizing matters here. The wider market backdrop reads extreme greed at 92 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 2/10 long-term conviction.

Top Market Events

Tamboran Resources Corp NYSE:TBN is among the best Australian stocks to buy in 2026.H&P Research has assigned Tamboran Resources Corporation NYSE:TBN, ASX:TBN, OTC:TBNRL, FRA:O8R a risked valuation...Tamboran Resources Corporation ASX:TBN, NYSE:TBN, OTC:TBNRL has completed the largest stimulation campaign undertaken...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 70.4 signals overbought conditions
  • Trading above the 200-day average of 31.92

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • RSI at 70.4 signals overbought conditions
  • Trading above the 200-day average of 31.92

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Analyst targets imply +38.5% versus the current price
  • Negative return on equity of -8.4%
  • Negative free cash flow

Key Metrics & Analysis

Financial Health

P/E Ratio-108.6
ROE-8.36%
ROA-3.69%
Debt/Equity12.95
P/B Ratio2.3
Op. Cash Flow$-33469368
Free Cash Flow$-138199840
Industry P/E21.8

Technical Analysis

TrendBullish
RSI70.4
Support$32.05
Resistance$41.94
MA 20$36.69
MA 50$34.11
MA 200$31.92
MACDBullish
VolumeIncreasing
Fear & Greed Index92.25

Valuation

Target Price$55.17
Upside/Downside38.51%
GradeFair
TypeBlend

Risk Assessment

Beta-0.08
Volatility39.85%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.